Advertisement

Bevacizumab alone at 5 mg/kg in an every-3-week schedule for patients with recurrent glioblastomas: a single center experience

Abstract

The use of bevacizumab is increasingly reported in neuro-oncology. The most common schedule is 10 mg/kg every 2 weeks. We retrospectively investigated the efficacy of a 3-week schedule of 5 mg/kg bevacizumab in patients with recurrent glioblastomas. Fourteen patients (median age, 46 years) were included in the study. The median number of bevacizumab cycles was 4 (range, 2-8). Five patients (36%) had a partial response, 7 (50%) had stable disease, and 2 (14%) had progressive disease. No grade III-IV toxicities were observed. The median progression-free and overall survival were 3.6 months and 6.4 months, respectively. Every-3-week low-dose singleagent bevacizumab showed substantial activity and a safe profile in patients with recurrent glioblastoma.

Tumori 2013; 99(5): 601 - 603

Article Type: ORIGINAL RESEARCH ARTICLE

DOI:10.1700/1377.15309

Authors

Gentian Kaloshi, Gramoz Brace, Arben Rroji, Teona Bushati, Ermir Roci, Mehmet Hoxha, Geldon Fejzo, Mentor Petrela

Article History

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

  • Kaloshi, Gentian [PubMed] [Google Scholar]
    Department of Neurosurgery, University Hospital Center “Mother Theresa”, Faculty of Medicine, University of Tirana, Tirana, Albania
  • Brace, Gramoz [PubMed] [Google Scholar]
    Department of Neurosurgery, University Hospital Center “Mother Theresa”, Faculty of Medicine, University of Tirana, Tirana, Albania
  • Rroji, Arben [PubMed] [Google Scholar]
    Department of Neurosurgery, University Hospital Center “Mother Theresa”, Faculty of Medicine, University of Tirana, Tirana, Albania
  • Bushati, Teona [PubMed] [Google Scholar]
    Department of Neurosurgery, University Hospital Center “Mother Theresa”, Faculty of Medicine, University of Tirana, Tirana, Albania
  • Roci, Ermir [PubMed] [Google Scholar]
    Department of Neurosurgery, University Hospital Center “Mother Theresa”, Faculty of Medicine, University of Tirana, Tirana, Albania
  • Hoxha, Mehmet [PubMed] [Google Scholar]
    Department of Neurosurgery, University Hospital Center “Mother Theresa”, Faculty of Medicine, University of Tirana, Tirana, Albania
  • Fejzo, Geldon [PubMed] [Google Scholar]
    Department of Neurosurgery, University Hospital Center “Mother Theresa”, Faculty of Medicine, University of Tirana, Tirana, Albania
  • Petrela, Mentor [PubMed] [Google Scholar]
    Department of Neurosurgery, University Hospital Center “Mother Theresa”, Faculty of Medicine, University of Tirana, Tirana, Albania

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.